Bright Health Group (BHG) Prices 51.35M Share IPO at $18/sh

Bright Health Group today announced the pricing of its initial public offering of 51,350,000 shares of its common stock at a price to the public of $18.00 per share. As part of the offering, Bright Health Group has granted the underwriters a 30-day option to purchase up to an additional 6,162,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds to Bright Health Group from the offering will be approximately $924.3 million (or $1.035 billion if the underwriters exercise their option to purchase additional shares of common stock in full), before deducting the underwriting discount and estimated offering expenses.

The shares are expected to begin trading on the New York Stock Exchange on June 24, 2021, under the ticker symbol “BHG.” The offering is expected to close on June 28, 2021, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC, Morgan Stanley and Barclays are acting as lead book-running managers for the offering. BofA Securities, Citigroup and Piper Sandler are acting as additional bookrunners. Nomura and RBC Capital Markets are acting as co-managers for the offering.

A registration statement on Form S-1 relating to these securities was declared effective by the Securities and Exchange Commission on June 23, 2021. The offering is being made only by means of a prospectus. When available, copies of the final prospectus relating to the initial public offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, collect telephone: 1-212-834-4533, or by emailing at [email protected]; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected]; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] or telephone at 1-888-603-5847.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

You May Also Be Interested In

• SB Energy (SBE) files for proposed IPO
• Fervo Energy signs 396 MW geothermal PPA with Google for Utah project
• XTEND deploys XOS-powered AtlasROVER to Asia-Pacific customer